Istituto Mediterraneo Per I Trapianti E Terapie Ad Alta Specializzazione S.r.l.
- Address
- lock Available on a paid plan
Respiratory Tract Diseases and Immune System Diseases
At Istituto Mediterraneo Per I Trapianti E Terapie Ad Alta Specializzazione S.r.l. in Palermo, clinical research focuses on lung health in people living with complex post-transplant and fibrotic conditions. The studies in this area explore ways to improve breathing function, protect transplanted lungs, and better understand treatment effects in serious chronic disease.
- Chronic lung allograft dysfunction and lung transplant rejection
- Idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
- Testing new treatments aimed at improving lung function and slowing disease progression
These trials reflect a strong interest in finding more effective options for patients with advanced respiratory disease, especially where immune-related complications and declining lung capacity are major concerns.
Virus Diseases and Transplant-Related Infection Research
This site also studies viral respiratory illness, with a particular emphasis on Respiratory Syncytial Virus in adults who have received organ transplants. The research is designed to improve prevention strategies and understand how the immune system responds in vulnerable patients.
- Respiratory Syncytial Virus Infections
- Immune response in lung transplant and kidney transplant recipients
- Evaluating a vaccine approach to reduce the risk of severe respiratory infection
By studying both protection and immune response, the research aims to support safer care for transplant recipients who face a higher risk of serious viral disease.
Specialized Pulmonology Research
The Unit of Pulmonology is involved in a small but focused clinical trial portfolio, with work centered on difficult-to-treat lung conditions and transplant-related complications. The research is aimed at assessing whether new therapies can improve lung performance, stabilize disease, or strengthen protection against infection.
- Improving outcomes in chronic lung disease after transplantation
- Evaluating treatment effectiveness in fibrotic lung disorders
- Supporting preventive care for high-risk respiratory infections
Overall, the clinical studies at this hospital combine transplant medicine, respiratory care, and immune-focused research to address important unmet needs in patient care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 10 therapeutic areas and 15 of 51 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 49 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 11 by active trials.
lock +10 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +8 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Istituto Mediterraneo Per I Trapianti E Terapie Ad Alta Specializzazione S.r.l.
lock Showing 1 of 28 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A PHASE 2A, OPEN-LABEL SINGLE ARM MULTICENTER EXPLORATORY STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF ORAL DOSES OF ROC-101 IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) AND PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE (ILD-PH) | Allrock Bio Inc. | Phase II | Recruiting | Feb 2026 | — |
IMP list
lock Showing 1 of 51 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Imatinib | 3 | Unknown | 2016-02-19 | 2023-05-05 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.